TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 173 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $25,767,113 | -68.3% | 1,225,255 | -62.9% | 0.16% | -70.9% |
Q3 2022 | $81,312,000 | +1.7% | 3,300,009 | 0.0% | 0.53% | +17.4% |
Q2 2022 | $79,959,000 | -6.0% | 3,300,009 | 0.0% | 0.45% | -7.2% |
Q1 2022 | $85,041,000 | +2.6% | 3,300,009 | +23.6% | 0.49% | +21.3% |
Q4 2021 | $82,847,000 | +67.5% | 2,669,054 | +30.9% | 0.40% | +85.7% |
Q3 2021 | $49,464,000 | +1713.9% | 2,039,772 | +991.3% | 0.22% | +1708.3% |
Q2 2021 | $2,727,000 | -41.6% | 186,915 | 0.0% | 0.01% | -40.0% |
Q1 2021 | $4,667,000 | – | 186,915 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 895,821 | $8,008,640 | 3.99% |
Deep Track Capital, LP | 7,370,000 | $65,887,800 | 2.54% |
VR Adviser, LLC | 2,623,677 | $23,455,672 | 2.47% |
Sio Capital Management, LLC | 884,770 | $7,909,844 | 2.45% |
Kynam Capital Management, LP | 957,502 | $8,560,068 | 1.40% |
MPM BioImpact LLC | 552,846 | $4,942,443 | 1.32% |
ARMISTICE CAPITAL, LLC | 7,500,000 | $67,050,000 | 1.03% |
Parkman Healthcare Partners LLC | 577,494 | $5,162,796 | 0.95% |
Tri Locum Partners LP | 251,702 | $2,250,216 | 0.72% |
Cheyne Capital Management (UK) LLP | 26,200 | $234,228 | 0.68% |